Immune signatures predict prognosis in localized cancer

Cancer Investigation

Volumn 28, Issue 7, 2010, Pages 765-773

  Hsu, David S ^a   Kim, Mickey K ^a   Balakumaran, Bala S ^a   Acharya, Chaitanya R ^a   Anders, Carey K ^b   Clay, Tim ^c   Lyerly, H Kim ^c   Drake, Charles G ^d   Morse, Michael A ^a,c   Febbo, Phillip G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c DUKE CANCER INSTITUTE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Cancer; Gene expression; Immunology

Indexed keywords

ADAPTIVE IMMUNITY; ADENOCARCINOMA; ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; CANCER LOCALIZATION; CANCER PATIENT; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; HOST; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; INFLAMMATION; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; SOLID TUMOR; TH1 CELL;

ADAPTIVE IMMUNITY; ADENOCARCINOMA; ADULT; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMMUNE TOLERANCE; INFLAMMATION; MALE; MIDDLE AGED; NEOPLASMS; PROGNOSIS;

EID: 77954801902     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357900903095755     Document Type: Article

References (24)

1. Balkwill, F.; Mantovani, A. Inflammation and cancer: back to Virchow? Lancet 2001, 357, 539-545.
2. Clemente, C.G.; Mihm, M.C., Jr.; Bufalino, R.; Zurrida, S.; Collini, P.; Cascinelli, N. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer 1996, 77, 1303-1310.
3. Coca, S.; Perez-Piqueras, J.; Martinez, D.; Colmenarejo, A.; Saez, M.A.; Vallejo, C.; Martos, J.A.; Moreno, M. The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer 1997, 79, 2320-2328.
4. Diederichsen, A.C.; Hjelmborg, J.B.; Christensen, P.B.; Zeuthen, J.; Fenger, C. Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells. Cancer Immunol Immunother 2003, 52, 423-428.
5. Ishigami, S.; Natsugoe, S.; Tokuda, K.; Nakajo, A.; Che, X.; Iwashige, H.; Aridome, K.; Hokita, S.; Aikou, T. Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer 2000, 88, 577-583.
6. Imada, A.; Shijubo, N.; Kojima, H.; Abe, S.Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma. Eur Respir J 2000, 15, 1087-1093.
7. Leek, R.D.; Landers, R.J.; Harris, A.L.; Lewis, C.E. Necrosis correlates with high vascular density and focalmacrophage infiltration in invasive carcinoma of the breast. Br J Cancer 1999, 79, 991-995.
8. Leek, R.D.; Lewis, C.E.; Whitehouse, R.; Greenall, M.; Clarke, J.; Harris, A.L. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 1996, 56, 4625-4629.
9. Ribatti, D.; Ennas, M.G.; Vacca, A.; Ferreli, F.; Nico, B.; Orru, S.; Sirigu, P. Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur J Clin Invest 2003, 33, 420-425.
10. Coussens, L.M.; Werb, Z. Inflammation and cancer. Nature 2002, 420, 860-867.
11. Pollard, J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004, 4, 71-78.
12. Galon, J.; Costes, A.; Sanchez-Cabo, F.; Kirilovsky, A.; Mlecnik, B.; Lagorce-Pages, C.; Tosolini, M.; Camus, M.; Berger, A.; Wind, P.; Zinzindohoue, F.; Bruneval, P.; Cugnenc, P.H.; Trajanoski, Z.; Fridman, W.H.; Pages, F. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006, 313, 1960-1964.
13. Chin, K.; DeVries, S.; Fridlyand, J.; Spellman, P.T.; Roydasgupta, R.; Kuo, W.L.; Lapuk, A.; Neve, R.M.; Qian, Z.; Ryder, T.; Chen, F.; Feiler, H.; Tokuyasu, T.; Kingsley, C.; Dairkee, S.; Meng, Z.; Chew, K.; Pinkel, D.; Jain, A.; Ljung, B.M.; Esserman, L.; Albertson, D.G.; Waldman, F.M.; Gray, J.W. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 2006, 10, 529-541.
14. Wang, Y.; Klijn, J.G.; Zhang, Y.; Sieuwerts, A.M.; Look, M.P.; Yang, F.; Talantov, D.; Timmermans, M.; Meijer-van Gelder, M.E.; Yu, J.; Jatkoe, T.; Berns, E.M.; Atkins, D.; Foekens, J.A. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005, 365, 671-679.
15. Miller, L.D.; Smeds, J.; George, J.; Vega, V.B.; Vergara, L.; Ploner, A.; Pawitan, Y.; Hall, P.; Klaar, S.; Liu, E.T.; Bergh, J. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci USA 2005, 102, 13550-13555.
16. Glinsky,G.V.; Glinskii, A.B.; Stephenson, A.J.; Hoffman, R.M.;Gerald, W.L. Gene expression profiling predicts clinical outcome of prostate cancer. J Clin Invest 2004, 113, 913-923.
17. Savage, K.J.; Monti, S.; Kutok, J.L.; Cattoretti, G.; Neuberg, D.; De Leval, L.; Kurtin, P.; Dal Cin, P.; Ladd, C.; Feuerhake, F.; Aguiar, R.C.; Li, S.; Salles, G.; Berger, F.; Jing, W.; Pinkus, G.S.; Habermann, T.; Dalla-Favera, R.; Harris, N.L.; Aster, J.C.; Golub, T.R.; Shipp, M.A. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma. Blood 2003, 102, 3871-3879.
18. Potti, A.; Mukherjee, S.; Petersen, R.; Dressman, H.K.; Bild, A.; Koontz, J.; Kratzke, R.; Watson, M.A.; Kelley, M.; Ginsburg, G.S.; West, M.; Harpole, D.H., Jr.; Nevins, J. R. A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006, 355, 570-580.
19. Horvath, S.; Zhang, B.; Carlson, M.; Lu, K.V.; Zhu, S.; Felciano, R.M.; Laurance, M.F.; Zhao, W.; Qi, S.; Chen, Z.; Lee, Y.; Scheck, A.C.; Liau, L.M.; Wu, H.; Geschwind, D.H.; Febbo, P.G.; Kornblum, H.I.; Cloughesy, T.F.; Nelson, S.F.; Mischel, P.S. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci USA 2006, 103, 17402-17407.
20. Golub, T.R.; Slonim, D.K.; Tamayo, P.; Huard, C.; Gaasenbeek, M.; Mesirov, J.P.; Coller, H.; Loh, M.L.; Downing, J.R.; Caligiuri, M.A.; Bloomfield, C.D.; Lander, E.S. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999, 286, 531-537.
21. De Visser, K.E.; Eichten, A.; Coussens, L.M. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 2006, 6, 24-37.
22. Anders, C.K.; Acharya, C.R.; Hsu, D.S.; Broadwater, G.; Garman, K.; Foekens, J.A.; Zhang, Y.; Wang, Y.; Marcom, K.; Marks, J.R.; Mukherjee, S.; Nevins, J.R.; Blackwell, K.L.; Potti, A. Age-specific differences in oncogenic pathway deregulation seen in human breast tumors. PLoS ONE 2008, 3, e1373.
23. Mantovani, A.; Bonecchi, R.; Locati, M. Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol 2006, 6, 907-918.
24. Bingle, L.; Brown, N.J.; Lewis, CE. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002, 196, 254-265.